Marc Lopez
6PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.Marc Lopez, Emerence Crompot, Emmanuelle Josselin
|Sep 23, 2022
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti
|May 09, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate.Olivier Cabaud, Ludovic Berger, Emerence Crompot
|Apr 14, 2021
EFA6B regulates a stop signal for collective invasion in breast cancer.Racha Fayad, Monserrat Vázquez Rojas, Mariagrazia Partisani
|Jan 13, 2016
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.Tania M Puvirajesinghe, François Bertucci, Ashish Jain
Pageof 1
Frequent Collaborators
4 joint publications
Pascal Finetti
4 joint publications
François Bertucci
3 joint publications
Emilie Mamessier
2 joint publications
Daniel Birnbaum
2 joint publications
Emerence Crompot
2 joint publications
Emmanuelle Charafe-Jauffret
2 joint publications
Anne Farina
1 joint publications
Michel Franco
1 joint publications
Olivier Cabaud
1 joint publications
José Adélaide
